MS
ABBV icon

Maven Securities’s AbbVie ABBV Stock Holding History

Maven Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,200
Closed -$3.48M – 387
2025
Q4 		$3.48M Sell
15,200
-17,100
-53% -$3.9M 0.08% 230
2025
Q3 		$7.48M Buy
32,300
+30,100
+1,368% +$6.13M 0.18% 116
2025
Q2 		$408K Sell
2,200
-13,800
-86% -$2.56M 0.01% 644
2025
Q1 		$3.35M Buy
16,000
+4,700
+42% +$914K 0.1% 187
2024
Q4 		$2.01M Buy
+11,300
New +$2.08M 0.05% 285
2024
Q3 		– Sell
-39,700
Closed -$6.81M – 858
2024
Q2 		$6.81M Buy
+39,700
New +$6.58M 0.15% 137
2024
Q1 		– Sell
-3,000
Closed -$465K – 340
2023
Q4 		$465K Sell
3,000
-300
-9% -$43.7K 0.01% 684
2023
Q3 		$492K Sell
3,300
-12,800
-80% -$1.88M 0.01% 814
2023
Q2 		$2.17M Sell
16,100
-17,500
-52% -$2.57M 0.03% 276
2023
Q1 		$5.35M Buy
33,600
+17,900
+114% +$2.74M 0.11% 122
2022
Q4 		$2.54M Sell
15,700
-2,900
-16% -$445K 0.06% 197
2022
Q3 		$2.5M Buy
18,600
+2,700
+17% +$387K 0.05% 258
2022
Q2 		$2.44M Sell
15,900
-5,600
-26% -$856K 0.07% 193
2022
Q1 		$3.48M Buy
21,500
+16,100
+298% +$2.34M 0.12% 117
2021
Q4 		$731K Buy
5,400
+100
+2% +$11.8K 0.02% 442
2021
Q3 		$572K Buy
+5,300
New +$606K 0.02% 620

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Maven Securities's ABBV Position: Q1 2026 in Review

Maven Securities sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 13,530 shares — an estimated $3M sold.

Maven Securities first reported a position in ABBV in Q4 2020 and held it in 12 quarters. The position peaked at $3.1M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Maven Securities reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Maven Securities sold 13,530 AbbVie shares in Q1 2026, an estimated $3M.
  • Maven Securities first reported a position in AbbVie in Q4 2020 and held it in 12 quarters.
  • Maven Securities's AbbVie position peaked at $3.1M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Maven Securities's 13F filing for Q1 2026, filed 15 May 2026.